Bulletin from general meeting in Phase Holographic Imaging PHI AB (publ)
Phase Holographic Imaging PHI AB (publ), reg.no. 556542-7811 (the “Company”) held a general meeting on 8 January 2025. The following resolutions were made.
Adoption of the income statement and balance sheet
The general meeting resolved to adopt the board of directors’ proposal for the income statement and the balance sheet for the fiscal year of 2023/24.
Disposition of the Company’s profit or loss
The general meeting resolved, in accordance with the board of directors’ proposal, that no dividend shall be paid and that the result for the year is carried forward.
Discharge from liability
The general meeting resolved to grant discharge from liability to all persons who have had the position of board member or CEO in the Company during the fiscal year 2023/24.
Election of members of the board of directors and auditor, and determination of fees
The general meeting resolved to re-elect Ivan Jorkovic, Goran Dubravcic, Mats Lundwall, Petter Björquist, John Moore and Peter Egelberg as members of the board.
The general meeting resolved that fees to non-employed board members elected by the general meeting shall be paid with two (2) income base amounts (Sw. inkomstbasbelopp) to the chairman, with one (1) income base amount each to the other board members and with half (0,5) an income base amount to a deputy board member. It was further resolved that for any additional work efforts in addition to ordinary board work, board members shall be able to receive consulting fees in line with market practice.
The general meeting resolved to re-elect the authorized public accounting firm Forvis Mazars AB as the Company’s auditor for the period until the next annual general meeting. Forvis Mazars AB has announced that the authorized auditor Anders Persson will be appointed as auditor in charge. Fees to the auditor shall be paid according to approved invoice.
Phase Holographic Imaging PHI AB (publ)
The Board of Directors
For additional information, please contact:
Anders Månsson
E-mail: ir@phiab.com
Web: www.phiab.com – Live cell imaging & analysis
About PHI
Phase Holographic Imaging (PHI) is a medical technology company that develops and markets its non-invasive time-lapse imaging instruments for long-term quantitative analysis of living cells. The foundation of PHI’s current commercial HoloMonitor® products is Quantitative Phase Imaging (QPI) technology — an innovative approach to cell quality evaluation. QPI offers detailed analysis of cell characteristics without harming the cells, avoiding the limitations of traditional measurement methods. PHI is actively focusing on business development to expand from pre-clinical research to the clinical market and the emerging regenerative medicine field. PHI envisions transforming live cell analysis and establishing QPI as a standard for cell quality control, making future cell therapies safe, affordable, and accessible for patients. PHI is based in Lund, Sweden, Boston, MA and Winston-Salem, NC.